Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study.

ABSTRACT:

Background

Lung cancers are common worldwide. First-line targeted therapy and chemotherapy are both standard treatments in the current guidelines. With the development of new anticancer therapy, the lifespan of patients with late-stage lung cancer has increased. Cardiovascular events can occur during cancer treatment. This observational study aimed to report the incidence of major adverse cardiovascular events (MACE) after cancer treatment using real-world data.

Objectives

Patients diagnosed with advanced-stage lung cancer between January 2011 and December 2017 were enrolled. Data were collected from the Chang Gung Research Database (CGRD).

Design

Retrospective cohort study.

Methods

Baseline characteristics, clinical stages, pathologies, and outcomes were retri

SUBMITTER: Chang CH 

PROVIDER: S-EPMC10798069 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature